Adult: Initially, 20-50 mg daily in 2 divided doses. Increase according to patient response and tolerance over the next 7-10 days to 60-100 mg daily or more, in 2-4 divided doses. Max dose: 250 mg daily. Maintenance dose range: 20-100 mg daily in divided doses.
Elderly: 20-60 mg/day.
Acute psychosis
Adult: Up to 300 mg daily in 2-3 divided doses.
Elderly: Reduced dose may be required.
Severe CNS depression, coma.
Warnings / Precautions
Parkinson's disease. Haemodynamic instability; bone marrow suppression; predisposition to seizures; subcortical brain damage; severe cardiac, hepatic, renal or respiratory impairment. Patients at risk of pneumonia (e.g. Alzheimer's disease). Breast cancer or other prolactin-dependent tumours. Cerebrovascular disease. Decreased GI motility, urinary retention, benign prostatic hyperplasia, xerostomia or visual problems. Narrow-angle glaucoma; myasthenia gravis. May impair ability to drive or operate machinery. Pregnancy and lactation.
Adverse Reactions
Arrhythmia, BP changes, orthostatic hypotension, tachycardia, syncope; agitation, ataxia, confusion, dizziness, drowsiness, extrapyramidal symptoms, faintness, headache, insomnia, lightheadedness, seizure, slurred speech, tension; sexual dysfunction, urinary retention; agranulocytosis, leukopenia, thrombocytopenia; muscle weakness; alopecia, dermatitis, photosensitivity, pruritus, rash, seborrhoea; amenorrhoea, irregular menstruation, breast enlargement, galactorrhoea, gynaecomastia; ileus, constipation, nausea, vomiting, polydipsia, wt changes, xerostomia; blurred vision; nasal congestion.
Potentially Fatal: Neuroleptic malignant syndrome.
Overdose Reactions
Symptoms: Deep sleep, dystonia, agitation, dysrhythmias, extrapyramidal reactions, hypotension, seizures. Management: Symptomatic and supportive.
Drug Interactions
Inhibits vasopressor effect of epinephrine.
Potentially Fatal: Additive CNS depression with other CNS depressants (e.g. benzodiazepines, barbiturates, alcohol).
See Below for More loxapine Drug Interactions
Lab Interactions
False-positive tests for phenylketonuria, amylase, uroporphyrins, urobilinogen.
Food Interactions
CNS depression may be increased with kava kava, gotu kola, valerian, St John's wort.
Mechanism of Actions
Loxapine, a dibenzoxazepine antipsychotic, antagonises central dopaminergic action by blocking postsynaptic mesolimbic D1 and D2 receptors in the brain. It also has serotonin 5-HT2 inhibiting activity.
Absorption: Absorbed readily from the GI tract; peak plasma concentrations within 1-2 hr.
Distribution: Widely distributed; crosses the placenta and distributes into breast milk.
Metabolism: Very rapidly and extensively hepatic. Major metabolites: 7- and 8-hydroxyloxapine.
Excretion: Mainly via urine (as conjugated metabolites); via faeces (small amounts as unconjugated metabolites). 12-19 hr (terminal elimination half-life).
Should be taken with food.
Storage Conditions
Oral: Store at 20-25°C (68-77°F).
ATC Classification
N05AH01 - loxapine ; Belongs to the class of diazepines, oxazepines and thiazepines antipsychotics.
Oral: Store at 20-25°C (68-77°F).
Available As
  • Loxapine 10 mg
  • Loxapine 25 mg
  • Loxapine 50 mg
  • Subscribe for latest updates

    Subscribe to our e-mail newsletter to receive updates.

    No comments yet.

    Post Review about Loxapine

    Loxapine Containing Brands

    We are Developing Our database, More results coming soon.

    Loxapine is used in following diseases

    We are Developing Our database, More results coming soon.

    Drug - Drug Interactions of Loxapine

    We are Developing Our database, More results coming soon.